ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Partner program
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,937 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical IndustryReinach BlSunRegen Healthcare AG
SunRegen Healthcare AG Logo
Verified· 3 sourcesTrust Score
Summary

About the company

The core activity of SunRegen Healthcare AG is the development of medications for the treatment of neurodegenerative diseases, particularly retinal neurodegenerations such as Retinitis Pigmentosa, age-related macular degeneration and glaucoma, as well as central nervous system neurodegenerations such as Alzheimer's, Huntington's, Parkinson's and ALS. The company focuses on the development of oral therapeutics that inhibit neuronal apoptosis and exhibit neuroprotective effects.

AI-generated
Offering

Products & services

Industry:Pharmaceutical Industry
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
4.0/5

SunRegen Healthcare AG

✓ Offered4
Oral Neurodegeneration Therapy (SBC003)
Oral small-molecule therapy for retinal and CNS neurodegeneration, with neuroprotective, neuro-rescuing and neurotrophic effects; in development for retinitis pigmentosa, dry AMD and optic atrophy.
Drug Development Pipeline for Retinal and CNS Diseases
Development pipeline covering IND-enabling work, preclinical development and indication expansion for retinitis pigmentosa, dry AMD, optic atrophy and CNS neurodegeneration.
Scientific Collaborations and Platform Licensing
Research and clinical-development partnerships, including platform licensing for compounds across retinal and CNS indications plus CRO, CMO and academic collaborations.
Equity Financing for Clinical Development
Series A financing to fund IND submission and Phase I/II trials in retinitis pigmentosa, aimed at institutional life science investors and strategic partners.
Trust & reputation

ranQ Trust Score of SunRegen Healthcare AG: 4.0 out of 5.0

Trust Score4.0/ 5.0

High

x

Data basis 58% · As of October 2026

SunRegen Healthcare AG has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
SunRegen Healthcare AG scores 78.3 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.83.012%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.55.07%
SunRegen Healthcare AG scores 85.0 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).85.022%
SunRegen Healthcare AG scores 19.3 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.28.64%
  • Media authority: Quality and number of editorial mentions, weighted by the importance of the source, plus the recency of the latest high-quality mention.10.04%
Qualifications+0.00

SunRegen Healthcare AG reaches a ranQ Trust Score of 4.0 out of 5.0 — rated «High». No public customer reviews are available for this provider; the rating is based on the remaining criteria. The data basis is 58%, so the score is backed by part of the criteria. As of October 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Press

Media

August 20, 2024Media
SunRegen Healthcare to go public via reverse takeover
startupticker.ch

Knowledge

No knowledge articles yet

Once SunRegen Healthcare AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

SunRegen Healthcare AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank SunRegen Healthcare AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of SunRegen Healthcare AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Robinienweg 51
4153 Reinach Bl

At a glance

Legal form
Corporation
UID
CHE-295.245.274
Founded
2017 · 9 years
Last commercial register change
July 7, 2025
Employees
1 to 10
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
100.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    BA
    Baliopharm AG
    Reinach Bl
    TP
    T3 Pharmaceuticals AG
    Allschwil
    SP
    Santhera Pharmaceuticals (Schweiz) AG
    Pratteln
    ST
    saverna therapeutics AG
    Biel-Benken Bl
    IA
    InCephalo AG
    Allschwil
    CT
    CAPTOR THERAPEUTICS GmbH
    Allschwil
    EA
    EpiPharm AG
    Binningen
    PP
    Perseo pharma AG
    Muttenz